Procter & Gamble Health Ltd

BSE Code : 500126
NSE Symbol : PGHL
ISIN : INE199A01012
Industry :PHARMACEUTICALS - MULTINATIONAL

Trade Now

Get Quotes

6,217.00 321.50(5.45%)

Open Price (₹)

5,895.50

Prev. Close (₹)

5,895.50

Volume (No’s)

241,190

Market Cap (₹)

10,319.84

Low Price (₹)

5,895.50

High Price (₹)

6,500.00

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
27-Jun-2025	01-Aug-2025	Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Dear Sir We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday August 1 2025 inter alia to consider and approve unaudited Financial Results for the quarter ended June 30 2025. Please find attached outcome of Board meeting dated August 1, 2025. Please find attached unaudited financial results for quarter ended June 30, 2025. (As Per BSE Announcement Dated on :01.08.2025)
26-Mar-2025	29-May-2025	Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 inter alia to consider and approve Audited Financial Statements for the Financial Year ended March 31 2025 and to consider recommendation of dividend (if any). We are pleased to inform you that a meeting of the Board of Directors of the Company held today (commenced at 12.40 pm and ended at 5.14 pm), the Audited Financial Results for the Financial Year ended March 31,2025 were approved. Find enclosed: a. Audited Financial Results for the Financial Year ended March 31,2025, b. Auditor's Report, in respect of the aforementioned Financial Results, c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a dividend of Rs. 45 per Equity Share, for the Financial Year ended March 31, 2025. The divided shall be paid on or before September 25, 2025, on approval of the Members at the ensuing Annual General Meeting (As Per BSE Announcement dated on 29.05.2025)
27-Dec-2024	12-Feb-2025	Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 12 2025 inter alia to consider and approve Unaudited Financial Results for the Quarter ended December 31 2024. Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Update on board meeting (As Per BSE Announcement Dated on: 31/01/2025) Find enclosed the unaudited financial results for the quarter ended December 31,2024 along with the limited review report and recommendation of interim dividend for the FY 2024-25 (As Per BSE Announcement Dated on: 12/02/2025)
27-Sep-2024	04-Nov-2024	Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday November 4 2024 inter alia to consider and approve Unaudited Financial Results for the Quarter ended September 30 2024. Find enclosed the unaudited financial results for the quarter ended September 30,2024 along with the limited review report on the same. (As per BSE Announcement Dated on 04/11/2024)
27-Jun-2024	21-Aug-2024	Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 21 2024 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30 2024 and to consider recommendation of dividend (if any). We are pleased to inform you that the Board at its meeting held today recommended a final dividend of Rs. 60 per equity share for the financial year ended June 30,2024 (As Per BSE Announcement Dated on 21.08.2024)